INVENTORIES



(Dollars in Millions)	April 3, 2016		January 3, 2016
Raw materials and supplies	$	957	936
Goods in process	1,930		2,241
Finished goods	5,283		4,876
Total inventories	$	8,170	8,053

Inventory of $236 million was classified as held for sale, and reported in prepaid expenses and other on the Consolidated Balance Sheet, related to the divestiture of the controlled substance raw material and active pharmaceutical ingredient (API) business which was pending as of April 3, 2016. See Note 10 to the Consolidated Financial Statements for more details related to the divestiture.